Burning Rock Biotech
BNR
HK$54.16
Share price
1.47%
Change (1 day)
1.38%
Change (1 year)
Categories
Burning Rock Biotech (BNR) - Cash on Hand
Cash on Hand as of March 2025 : HK$0.53 Billion
According to Burning Rock Biotech's latest financial reports the company has HK$0.53 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Burning Rock Biotech - Cash on Hand chart (from 2019 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | HK$0.67 B | -33.74% |
| 2022-12-31 | HK$1.02 B | -43.93% |
| 2021-12-31 | HK$1.82 B | -31.81% |
| 2020-12-31 | HK$2.68 B | 489.56% |
| 2019-12-31 | HK$0.45 B | 207.15% |
| 2018-12-31 | HK$0.14 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OpGen
OPGN | HK$12.81 M | -97.61% | 🇺🇸 USA |
 NeoGenomics
NEO | HK$2.81 B | 424.79% | 🇺🇸 USA |
 LabCorp LH | HK$2.89 B | 441.38% | 🇺🇸 USA |